Engaging with our stakeholders is essential to build trust, develop an understanding of our business challenges and jointly develop solutions
Open and constructive dialogue with our stakeholders is crucial to improving our ability to create sustainable value and growth. It helps us to better understand how to serve patients, their caretakers and physicians, and to focus our activities to create value for both the company and society.
The interests of our stakeholders are as diverse as the groups themselves – patients and patient organisations, healthcare professionals, payors, regulatory authorities and other government organisations, non-profit organisations, the scientific community, suppliers, service providers, investors, trade and business associations, media, our employees and society in general. We use a variety of channels to support our communications, such as corporate websites, annual reports and other publications. In addition, we participate in more formal and structured engagement, such as meetings, forums and other events, and carry out consultations and surveys.
We have established Group-wide guidelines and policies to govern our interactions with stakeholder groups. Transparency about relations between healthcare companies and a variety of stakeholders has become a topic of increasing interest, as has the amount of information available to those who are interested. Hence, we have taken numerous steps to improve our communication and transparency around key topics. In addition, we have developed a number of position papers on sustainability topics; each addresses specific expectations and concerns of our stakeholders.
Media contacts are managed by experts in the Media Relations team, whilst interactions with investors are dealt by the Investor Relations team. Roche employees must direct all media and investor inquiries to these teams.